fhtx: the income statement

MyFinsight

Foghorn Therapeutics Inc. (FHTX)

For the year ending 2024-12-31, FHTX made $22,602K in revenue. -$85,659K in net income. Net profit margin of -378.99%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2024-12-31
Collaboration revenue	22,602
Research and development	94,528
Impairment of long-lived assets	2,398
General and administrative	28,359
Total operating expenses	125,285
Loss from operations	-102,683
Interest income	11,900
Other income, net	4,163
Total other income, net	16,063
Loss before income taxes	-86,620
Net loss	-86,620
Unrealized gains on marketable securities	961
Total other comprehensive gain	961
Total comprehensive loss	-85,659

Basic eps	-1.58
Diluted eps	-1.58
Basic average shares	54,899,432
Diluted average shares	54,899,432

Unit: Thousand (K) dollars (except for numbers of shares and EPS)